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BACKGROUND: Psoriatic plaques have been shown to
contain increased levels of proinflammatory cyto-
kines. Serum levels of interleukin (IL)-6, IL-7, IL-8,
and interferon (IFN)-g have been reported elevated in
psoriatic patients.
Aim: To evaluate serum cytokine profiles in psoriasis
patients by improved enzyme-linked immunosorbent
assay (ELISA) technique and to correlate these levels
with disease severity.
Methods: We analyzed single serum samples from 10
patients with active untreated psoriasis, two patients
with active treated psoriasis, and five healthy volun-
teers for major T helper type 1 and T helper type 2
cytokines using the LINCOplex ELISA multi-analyte
detection system that permits simultaneous detection
of multiple cytokines from a single sample. The
disease severity, including erythema, induration,
scale, and surface area, was assessed.
Results: IFN-g was markedly elevated in all sera from
psoriasis patients, 33.89 /1.3 pg/ml (mean9 /standard
error) versus 89 /1.5 pg/ml for normal controls (p B/
0.01), and positively correlated with all indices of
disease severity (Spearman r /0.6). IL-8 was also
increased in psoriasis patients (24.49 /1.8 pg/ml)
versus normal controls (3.69 /1.2 pg/ml) (p B/0.05)
and positively correlated with the degree of erythema
(Spearman r  /0.6). Mean IL-12 levels were decreased
in sera from psoriasis patients (8.59 /1.2 pg/ml)
compared with normal controls (42.29 /5.3 pg/ml)
(p B/0.01). Also, serum IL-10 levels were below
detection levels in psoriatics compared with controls
(6.49 /1.3 pg/ml).
Conclusions: This new ELISA system allowed rapid
and reliable detection of numerous cytokines in
single serum samples from patients with psoriasis.
We observed that IFN-g and IL-8 cytokines were
elevated in psoriatics and correlated with parameters
of disease severity while IL-10 and IL-12 were de-
creased.
Mediators of Inflammation, 12(5), 309/313 (October 2003)
Simultaneous measurement of
multiple Th1 and Th2 serum
cytokines in psoriasis and
correlation with disease severity
Sharon E. Jacob
1, Mehdi Nassiri
2, Francisco A.
Kerdel
1 and Vladimir Vincek
2,CA
1Department of Dermatology and Cutaneous Surgery
and
2Department of Pathology, University of Miami/
Jackson Memorial Medical Center, Holtz Center,
Room 2042, 1611 NW 12 Avenue, Miami, FL 33136,
USA
CACorresponding author
Tel:  /1 305 585 6484
Fax:  /1 305 3269523
E-mail: vvincek@med.miami.edu
Introduction
Psoriasis vulgaris is a persistent chronic relapsing,
inflammatory and hyperproliferative skin disorder
with genetic predisposition. In the United States,
psoriasis affects approximately 2% of the population.
There is currently no good experimental model for
psoriasis. Psoriatic plaques have been shown to
contain increased levels of cytokines, including
tumor necrosis factor-alpha (TNF-a), interleukin
(IL)-6, IL-1a, IL-1ra, IL-8R
1,2 and macrophage migra-
tion inhibitory factor,
3,4 whereas IL-10 expression has
been shown to be lower than in perilesional skin.
5
While TNF-a appears to be playing a critical role in
propagation of lesional psoriatic plaques, serum TNF-
a has been reported to be within normal limits.
6 On
the contrary, serum IL-6, IL-8, and interferon-gamma
(IFN-g) have been reported significantly elevated in
the sera of psoriatic patients with active disease.
5,7 It
has been reported that IL-6 elevation positively
correlates with Psoriatic Assessment and Severity
Index scores. A negative correlation has been seen
with IL-1a levels and disease activity.
6,7 In patients
with psoriatic arthritis sIL-2R, IL-1ra, and IL-10 were
found to be elevated in the sera during periods of
disease activity. Of special note, sIL-2R has been
shown to have a significant association with the
severity of skin involvement, whereas IL-1ra corre-
lates with the number of tender/swollen joints.
5 The
current state of knowledge suggests that over-expres-
sion of proinflammatory, type 1, cytokines and the
under-expression of type 2 cytokines are of patholo-
gical significance in psoriasis. As the psoriatic story
unfolds, we need more reliable and rapid tests to
elucidate the biological relevance of Th1 versus Th2
cytokines in the pathogenesis of psoriasis. Moreover,
the measurement of these cytokines may allow for
better monitoring and prediction of disease activity.
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Twelve psoriatic patients were admitted to dermatol-
ogy inpatient ward at Cedars Medical Center/Uni-
versity of Miami for Goeckerman therapy for
recalcitrant psoriasis.
8 Of the 12 patients selected
for enrollment in this University of Miami Institutional
Review Board-approved study, nine had plaque
psoriasis, two had guttate and one had erythroderma.
Out of nine plaque psoriasis patients, seven had
received no systemic therapy and two were on
methotrexate. The guttate and erythrodermic patients
had not received systemic therapy at the time of the
inclusion in the study.
At the time of admission, the patients were
assessed by the same physician and assigned scores
for four indices of disease severity. Independent
scores for body surface area (BSA) involvement,
degree of erythema, thickness and scale of a target
plaque that denoted the severity of the patients
disease state were given. Score for percent BSA
involvement was from 1 (0/20%), 2 (20/40%), 3
(40/60%), 4 (60/80%) to 5 (80/100%). A target
lesion was selected for assessment; thickness was
scored from 0 (flat), 1 (minimal thickness), 2 (mild), 3
(moderate) to 4 (severe). The target lesion was
assessed for erythema as follows: 0 (none), 1 (mini-
mal), 2 (mild), 3 (moderate), and 4 (severe). Scaling
of the target lesion was assessed as: 0 (none), 1
(minimal), 2 (mild), 3 (moderate), 4 (severe). On
admission the patient’s vital signs, weight and base-
line laboratory data were drawn. Each patient con-
sented to the use of residual blood from a routine
laboratory draw to measure serum cytokine levels. In
addition five healthy non-psoriatic volunteers with no
family history of psoriasis consented to have their
blood drawn for the purpose of measuring serum
cytokine levels.
For the purpose of the assay, 25 ml of sera was used
to measure IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-
12, IFN-g, granulocyte/monocyte colony-stimulating
factor (GM-CSF), and TNF-a. Measurements were
made by LINCOplex simultaneous multi-analyte de-
tection system (Linco Research Inc., St Charles,
Missouri, USA) following manufacturer’s instruction.
All cytokines are simultaneously measured from a
single specimen. The LINCOplex assay was shown to
produce results comparable with standard single
cytokine assays.
9 Statistical analysis of the results
was performed with the aid of Statistical Software
(StatSoft, Tulsa, Oklahoma, USA).
Results
Serum cytokine levels of major Th1 and Th2 type
cytokines were simultaneously measured from the
single specimen prior to initiation of therapy in
patients with recalcitrant psoriasis. Results are pre-
sented in Table 1. Th2 type cytokine, IL-10, was
undetectable in psoriatic patients, of any type,
compared with controls (6.49 /1.3 pg/ml). The IL-5,
another of the Th2 type cytokines, was not detected
in normal nor psoriatic patients. The remaining two
tested Th2 type cytokines, IL-4 and IL-6, were present
at similar low level in psoriasis patients and normal
controls, with the exception that in two psoriasis
patients both were significantly increased.
When compared with normal sera, the level of Th1
type cytokine IFN-g was markedly elevated in all sera
from psoriasis patients, 33.89 /1.3 pg/ml (mean9 /
standard error) versus 7.69 /2.2 pg/ml for normal
controls (p B/0.01). Besides, when IFN-g was com-
pared with clinical indices of disease severity, it
showed positive correlation (Spearman rank order
test: BSA, r/0.64; thickness, r/0.62; erythema, r/
0.7; scale, r/0.67; pB/0.05). The IL-2, another Th-1
type cytokine, did not show elevation in the serum of
psoriasis patients, whereas IL-12 was decreased in
psoriatics (8.59 /1.2 pg/ml) compared with normal
controls (42.29 /5.3 pg/ml, pB/0.01). From three
tested cytokines that cannot be clearly defined as
Th1 or Th2, IL-8, TNF-b, and GM-CSF, only IL-8 was
significantly increased in serum of psoriatic patients
(24.49 /1.8 pg/ml), compared with normal controls
(3.69 /1.2 pg/ml, pB/0.05) and positively correlated
with the degree of erythema (Spearman r  /0.6; pB/
0.05). Fig. 1 illustrates the correlation of the erythema
score with serum level of IFN-g and IL-8.
Discussion
Our study shows for the first time that 11 major
human cytokines, including the major Th1 and Th2
cytokines, were simultaneously quantitatively deter-
mined from a single sample in the serum of psoriatic
patients. In prior studies solitary cytokines were
measured in separate ELISA studies that can poten-
tially cause variation in results due to the variation
between samples and individual experiments.
7,10 In
our testing using LINCOplex kit and Luminex tech-
nology (Linco Research Inc.) 11 captured antibodies
for specific cytokines were coupled to specific bead
sets with different fluorophores. After analytes were
bound to the capture antibody on the beads, a
detector antibody coupled to phycoerythrin is used
as a reporter. The assay was read using a dual laser
system. Using multiple bead sets, 11 different assays
were simultaneously performed and detected on the
individual serum samples. Performing cytokine test-
ing that way means variation between test samples
and individual experiments is eliminated. In addition,
the cost of testing is significantly decreased.
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kines is believed to be of pathogenic significance in
psoriasis.
11 Our data confirm previously published
data that the Th1 type cytokine IFN-g is elevated in
the serum of psoriatic patients. In addition our data
suggest that the serum level of IFN-g correlates with
clinical indices of severity that could potentially be
used to monitor progression of traditional psoriatic
therapy. However, the other two tested Th1 type
cytokines, IL-2 and IL-12, did not show significant
increase between psoriatic patients and normal con-
trols. On the contrary, IL-12 showed a significant
decrease in psoriatic patients. A normal level of IL-2
could be expected since it induces proliferation of
activated T and B cells. On the contrary, the fact that
IL-12 was not elevated but rather decreased was not
expected, as IL-12 is a fundamental cytokine for Th1
differentiation. It induces proliferation and IFN-g
production by Th1 lymphocytes. The observation
that IFN-g is elevated in psoriatic patients, while IL-12
is decreased, suggests that in psoriasis patients IFN-g
production might be induced by another pathway.
Among the tested Th2 type cytokines, we found a
significant decrease of the IL-10 serum cytokine level
in the patients with psoriasis. This dramatic suppres-
sion of IL-10 was a constant feature. IL-10 is an anti-
inflammatory cytokine that suppresses macrophage
production of cytokines/chemokines and enhances
soluble cytokine receptor release. It is known that IL-
10 modulates antigen presentation by dendritic cells
and suppresses co-stimulatory reactions by a direct
action on T cells. McInnes et al. demonstrated that a
28-day course of subcutaneous recombinant human
IL-10 provided clinically significant improvement of
the skin but not the articular disease in 29 patients
with psoriatic arthritis. The administration of recom-
binant human IL-10 also caused a selective functional
suppression of the pro-inflammatory activities of
circulating monocytes.
12 Low levels of IL-10 have
been observed in the cutaneous lesions of psoriatic
patients and with established antipsoriatic therapy
higher IL-10 mRNA levels can be found in peripheral
blood mononuclear cells. Thus, it is consistent that
serum levels of IL-10 in our patients were decreased.
Interestingly, patients with psoriatic arthritis have
been shown to have increased serum levels of IL-
10,
1 which probably represents a compensatory
attempt of these patients with both skin and articular
disease to regulate the inflammatory process. Other
tested Th2 type cytokines, IL-4, IL-5, and IL-6, had
serum levels comparable with normal controls.
Although previously IL-6 was shown to be elevated
in serum of patients with active psoriasis,
1 our data
did not confirm this. However, there were two
patients of the 12 that demonstrated elevated serum
IL-4 and IL-6 levels, in addition to one normal control
that had elevated IL-6. Elevated IL-4 and IL-6 did not
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Serum cytokines in psoriasis and disease severity
Mediators of Inflammation Vol 12  2003 311correlate with BSA score. We do not have a good
explanation for that observation.
As per previous reports, we found that patients
with psoriatic skin disease had normal serum levels
of TNF-a, significantly higher IFN-g and moderately
increased IL-8.
4,6,7 We were able to furthermore
demonstrate an association between serum level of
IFN-g and clinical indices of severity.
Among the tested cytokines there were three (TNF-
a, GM-CSF, IL-8) that cannot be clearly classified as
Th1 or Th2. TNF-a, while significantly elevated in the
lesional psoriatic plaques of patients, is known to be
at normal levels in the psoriatic patient’s sera. Our
data support previous findings. Even in the patients
with an erythroderma the TNF-a level was normal. Of
note, TNF-a levels have been noted to remain
unchanged after standard psoriasis therapy.
7 GM-
CSF was not elevated in our patient population. To
our knowledge GM-CSF in psoriasis has not been
previously reported.
We found IL-8 to be elevated in our patients. The
level of IL-8 was found to positively correlate with
degree of erythema. IL-8 is a known chemotactic
factor for neutrophils and, by an indirect mechanism,
induces neutrophil degranulation. As neutrophils are
present in the epidermis of the psoriatic lesions, it is
possible that IL-8 aids in their recruitment and thus
contributes to the erythema. While the kinetics of IL-8
in the serum of patients with psoriasis are not known,
one could presume that IL-8 could be a good index
for the inflammatory process and a crucial element in
the cellular activation of psoriasis.
Among the tested psoriatic patients, two were on
methotrexate therapy. This number of patients is not
adequate to draw definitive conclusive data.
We realize the limitations of our data, since we had
a small number of patients. Yet, with the mounting
body of scientific evidence in the literature, and our
congruent results we are able to conclude that
psoriasis is not, as many times inferred, a Th1 versus
Th2 disease. Rather it is a complex disease in which
the cytokine network is dysregulated with only some
components of the Th1/Th2 cytokine network being
involved. The new technique that we utilized in our
study is rapid, flexible, and inexpensive compared
with the traditional ELISA, and requires a very small
amount of serum for testing. It could be modified in
the future, to test specific cytokines relevant in
psoriasis, to better understand the pathophysiology
of psoriasis, and to possibly serve as an objective tool
to assess severity, progression and prognosis.
Furthermore, the manipulation of these cytokines
may allow for new and more specific therapeutic
alternatives.
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